Herenu CB - Search Results

1

Reversal of Biological Age in Multiple Rat Organs by Young Porcine Plasma Fraction.

Horvath S, Singh K, Raj K, Khairnar S, Sanghavi A, Shrivastava A, Zoller JA, Li CZ, Herenu CB, Canatelli-Mallat M, Lehmann M, Habazin S, Novokmet M, Vučković F, Woods LCS, Martinez AG, Wang T, Chiavellini P, Levine AJ, Chen H, Brooke RT, Gordevicius J, Lauc G, Goya RG, Katcher HL. Horvath S, et al. Among authors: herenu cb. bioRxiv [Preprint]. 2023 Aug 7:2023.08.06.552148. doi: 10.1101/2023.08.06.552148. bioRxiv. 2023. PMID: 37609328 Free PMC article. Updated. Preprint.

2

Neuroendocrinology of aging: the potential of gene therapy as an interventive strategy.

Goya RG, Bolognani F, Hereñú CB, Rimoldi OJ. Goya RG, et al. Among authors: herenu cb. Gerontology. 2001 May-Jun;47(3):168-73. doi: 10.1159/000052792. Gerontology. 2001. PMID: 11340324 Review.

3

Hypophysiotropic activity of histone H3 in vitro.

Brown OA, Sosa YE, Naumovich D, Hereñú CB, Goya RG. Brown OA, et al. Among authors: herenu cb. Peptides. 2003 May;24(5):671-8. doi: 10.1016/s0196-9781(03)00132-3. Peptides. 2003. PMID: 12895652

4

Potential of gene therapy for the treatment of pituitary tumors.

Goya RG, Sarkar DK, Brown OA, Hereñú CB. Goya RG, et al. Among authors: herenu cb. Curr Gene Ther. 2004 Mar;4(1):79-87. doi: 10.2174/1566523044578086. Curr Gene Ther. 2004. PMID: 15032616 Free PMC article. Review.

5

The neuroendocrine system as a model to evaluate experimental gene therapy.

Hereñú CB, Brown OA, Sosa YE, Morel GR, Reggiani PC, Bellini MJ, Goya RG. Hereñú CB, et al. Curr Gene Ther. 2006 Feb;6(1):125-9. doi: 10.2174/156652306775515556. Curr Gene Ther. 2006. PMID: 16475950 Review.

6

Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats.

Reggiani PC, Hereñú CB, Rimoldi OJ, Brown OA, Pléau JM, Dardenne M, Goya RG. Reggiani PC, et al. Among authors: herenu cb. Gene Ther. 2006 Aug;13(16):1214-21. doi: 10.1038/sj.gt.3302775. Epub 2006 Apr 13. Gene Ther. 2006. PMID: 16617301

7

Peripheral and mesencephalic transfer of a synthetic gene for the thymic peptide thymulin.

Morel GR, Brown OA, Reggiani PC, Hereñú CB, Portiansky EL, Zuccolilli GO, Pléau JM, Dardenne M, Goya RG. Morel GR, et al. Among authors: herenu cb. Brain Res Bull. 2006 May 31;69(6):647-51. doi: 10.1016/j.brainresbull.2006.03.015. Epub 2006 Apr 18. Brain Res Bull. 2006. PMID: 16716832

8

Gene therapy in the neuroendocrine system.

Hereñú CB, Morel GR, Bellini MJ, Reggiani PC, Sosa YE, Brown OA, Goya RG. Hereñú CB, et al. Front Horm Res. 2006;35:135-142. doi: 10.1159/000094316. Front Horm Res. 2006. PMID: 16809929 Review.

9

Restorative effect of insulin-like growth factor-I gene therapy in the hypothalamus of senile rats with dopaminergic dysfunction.

Hereñú CB, Cristina C, Rimoldi OJ, Becú-Villalobos D, Cambiaggi V, Portiansky EL, Goya RG. Hereñú CB, et al. Gene Ther. 2007 Feb;14(3):237-45. doi: 10.1038/sj.gt.3302870. Epub 2006 Sep 21. Gene Ther. 2007. PMID: 16988717

10

Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas.

Console GM, Herenu CB, Camihort GA, Luna GC, Bracamonte MI, Morel GR, Goya RG. Console GM, et al. Among authors: herenu cb. Mol Cancer. 2008 Jan 25;7:13. doi: 10.1186/1476-4598-7-13. Mol Cancer. 2008. PMID: 18218140 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page